Rob De Jong

Associate Director, Antibody Research & Technology
Rob De Jong
Dr. Rob de Jong has worked in different roles at Genmab since 2007, spanning a.o. molecular biology, CMC-supportive research, and protein engineering and is an inventor of Genmab’s HexaBody® and HexElect® technologies. He currently leads Genmab’s Antibody Format Development efforts, aimed at translating biomolecular and structural insights into novel therapeutic antibody platform technologies.


No data was found

Download Brochure

Full details regarding the Biologics Series are available for download in the Conference Brochure